These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11791689)

  • 21. Bioavailability and metabolism of mometasone furoate following administration by metered-dose and dry-powder inhalers in healthy human volunteers.
    Affrime MB; Cuss F; Padhi D; Wirth M; Pai S; Clement RP; Lim J; Kantesaria B; Alton K; Cayen MN
    J Clin Pharmacol; 2000 Nov; 40(11):1227-36. PubMed ID: 11075308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a dry powder inhaler, the Ultrahaler, containing triamcinolone acetonide using in vitro-in vivo relationships.
    Lim JG; Shah B; Rohatagi S; Bell A
    Am J Ther; 2006; 13(1):32-42. PubMed ID: 16428920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma.
    Schmier J; Leidy NK; Gower R
    J Asthma; 2003 Jun; 40(4):383-93. PubMed ID: 12870834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of two dry-powder inhalers for the administration of mometasone furoate in asthma patients.
    Pereira CA; Vianna FF; Cukier A; Stelmach R; Oliveira JC; Carvalho EV; Gomes EP; Mayo SV; Chibante AM; Domingues CP
    J Bras Pneumol; 2010; 36(4):410-6. PubMed ID: 20835586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A; Larivee P; Eller J; Cockcroft DW; Ghaly L; Harris AG
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.
    Kemp JP; Berkowitz RB; Miller SD; Murray JJ; Nolop K; Harrison JE
    J Allergy Clin Immunol; 2000 Sep; 106(3):485-92. PubMed ID: 10984368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.
    Nayak AS; Banov C; Corren J; Feinstein BK; Floreani A; Friedman BF; Goldsobel A; Gottschlich GM; Hannaway PJ; Lampl KL; Lapidus RJ; Lawrence M; Lumry W; Munk Z; Pearlman D; Scardella AT; Schenkel EJ; Segal AT; Segall N; Silverman B; Shneyer L; Nolop KB; Harrison JE
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):417-24. PubMed ID: 10795650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma.
    Karpel J; D'urzo A; Lockey RF
    J Asthma; 2008 Nov; 45(9):747-53. PubMed ID: 18972289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
    Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
    Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge.
    Inman MD; Watson RM; Rerecich T; Gauvreau GM; Lutsky BN; Stryszak P; O'Byrne PM
    Am J Respir Crit Care Med; 2001 Aug; 164(4):569-74. PubMed ID: 11520717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy and safety of mometasone furoate dry powder inhaler and budesonide Turbuhaler.
    Carlsson LG; Edsbäcker S
    Eur Respir J; 2001 Jun; 17(6):1332-3. PubMed ID: 11491182
    [No Abstract]   [Full Text] [Related]  

  • 32. In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates.
    Feddah MR; Brown KF; Gipps EM; Davies NM
    J Pharm Pharm Sci; 2000; 3(3):318-24. PubMed ID: 11177650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild asthma.
    Skoner DP; Gentile DA; Angelini B
    Allergy Asthma Proc; 2010; 31(1):10-9. PubMed ID: 20167141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-year treatment with mometasone furoate in chronic obstructive pulmonary disease.
    Calverley PM; Rennard S; Nelson HS; Karpel JP; Abbate EH; Stryszak P; Staudinger H
    Respir Res; 2008 Nov; 9(1):73. PubMed ID: 19014549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.
    Zetterström O; Dahl R; Lindqvist A; Olsson P
    Respir Med; 2008 Oct; 102(10):1406-11. PubMed ID: 18640826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of mometasone furoate administered by metered dose inhaler with beclomethasone dipropionate.
    Chervinsky P; Nelson HS; Bernstein DI; Berkowitz RA; Siegel SC
    Int J Clin Pract; 2002; 56(6):419-25. PubMed ID: 12166539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma.
    Corren J; Berkowitz R; Murray JJ; Prenner B
    Int J Clin Pract; 2003 Sep; 57(7):567-72. PubMed ID: 14529054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers.
    Smith KJ; Chan HK; Brown KF
    J Aerosol Med; 1998; 11(4):231-45. PubMed ID: 10346666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma.
    Berger WE; Bensch GW; Weinstein SF; Skoner DP; Prenner BM; Shekar T; Nolte H; Teper AA
    Pediatr Pulmonol; 2014 May; 49(5):441-50. PubMed ID: 24019197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled mometasone furoate: A review of its use in persistent asthma in adults and adolescents.
    McCormack PL; Plosker GL
    Drugs; 2006; 66(8):1151-68. PubMed ID: 16789800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.